SNPHY - Santen Pharmaceutical Co. reports FY results May, 11 2023 12:32 PM Santen Pharmaceutical Co. Ltd. ADR 2023-05-11 12:32:48 ET Santen Pharmaceutical Co. press release ( OTCPK:SNPHY ): FY core net profit of ¥33.2B. Revenue of ¥279B (+4.8% Y/Y). FY23 revenue expected to be ¥273.0B and core net profit of ¥34.5B. For further details see: Santen Pharmaceutical Co. reports FY results